Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Contemporary Clinical Trials|October 6, 2010
Statistical methods for a phase II oncology trial with a growth modulation index (GMI) endpointStephanie Kovalchik, William Mietlowski
Journal of Biopharmaceutical Statistics|December 31, 2010
An efficient algorithm to determine the optimal two-stage randomized multinomial designs in oncology clinical trialsYong Zhang, William Mietlowski, Bee Chen, et al.
European Urology|December 11, 2012
Survival prediction in everolimus-treated patients with metastatic renal cell carcinoma incorporating tumor burden response in the RECORD-1 trialAndrew Stein, Joaquim Bellmunt, Bernard Escudier, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2011
Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastomaDavid A Reardon, Timothy Cloughesy, Jeremy Rich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2012
Using pharmacokinetic and pharmacodynamic data in early decision making regarding drug development: a phase I clinical trial evaluating tyrosine kinase inhibitor, AEE788José Baselga, Alain C Mita, Patrick Schöffski, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2012
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patientsDavid A Reardon, Charles A Conrad, Timothy Cloughesy, et al.
The New England Journal of Medicine|June 16, 2006
Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALLHagop Kantarjian, Francis Giles, Lydia Wunderle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2003
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studiesBruno Morgan, Anne L Thomas, Joachim Drevs, et al.
Pageof 1